2022 Annual Meeting | C59 - COVID-19 and Neuromuscular Disorders

Date Sunday 04/03/22

Time 03:30 PM - 05:30 PM PDT Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program will be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Pushpa Narayanaswami, MD, MBBS, FAAN

Topic(s) Infectious Disease, Neuromuscular and Clinical Neurophysiology (EMG)

Learning Objectives Participants should be able to: Discuss the effects of infections, including COVID-19, on patients with underlying neuromuscular diseases (NMD) and identify NMDs associated with preceding infections; List the available COVID-19 vaccines, identify their mechanisms of action and describe the effectiveness and adverse effects of these vaccines to apply to clinical practice; Create a plan for infection prevention in patients with NMD including monitoring, prophylaxis and immunization.

CME Available 2.00 CME credits

Core Competencies Patient Care & Procedural Skills, Medical Knowledge

Program Level Intermediate

Recommended Audience Fellow, Resident, General Neurologist, Specialist Neurologist, Non-neurologist, Advanced Practice Provider, Medical Student

Teaching Styles Didactic, Audience Participation

Program Materials Program Evaluations

Event Timeline
03:30 PM - 03:35 PM PDT	Introduction	Course Overview Pushpa Narayanaswami, MD, MBBS, FAAN
03:30 PM - 03:30 PM PDT	Speaker	walk in slides Pushpa Narayanaswami, MD, MBBS, FAAN
03:35 PM - 04:10 PM PDT	Speaker	Infections and Neuromuscular Disorders Gregory Gruener, MD
04:10 PM - 04:45 PM PDT	Speaker	Efficacy and Safety of SARS CoV-2 Vaccines Pushpa Narayanaswami, MD, MBBS, FAAN
04:45 PM - 05:20 PM PDT	Speaker	Infection Prevention in Neuromuscular Disorders Sasha Zivkovic, MD, FAAN
05:20 PM - 05:30 PM PDT	Q&A	Questions and Answers Pushpa Narayanaswami, MD, MBBS, FAAN, Sasha Zivkovic, MD, FAAN, Gregory Gruener, MD

Faculty Disclosures
Pushpa Narayanaswami, MD, MBBS, FAAN	Dr. Narayanaswami has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UCB. Dr. Narayanaswami has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Narayanaswami has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Narayanaswami has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Dr. Narayanaswami has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx USA. Dr. Narayanaswami has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Narayanaswami has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Muscle and Nerve, Wiley. Dr. Narayanaswami has stock in Moderna. Dr. Narayanaswami has stock in Dr. Reddys laboratories. Dr. Narayanaswami has stock in Pfizer. Dr. Narayanaswami has stock in Viatris. Dr. Narayanaswami has stock in Doximity. The institution of Dr. Narayanaswami has received research support from Alexion. Dr. Narayanaswami has a non-compensated relationship as a Member, Medical and Scientific Advisory Board with Myasthenia Gravis Foundation of America that is relevant to AAN interests or activities. Dr. Narayanaswami has a non-compensated relationship as a Member, Board of Directors with AANEM that is relevant to AAN interests or activities.
Sasha Zivkovic, MD, FAAN	Dr. Zivkovic has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. Dr. Zivkovic has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alnylam. Dr. Zivkovic has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Takeda. Dr. Zivkovic has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CSL Behring. Dr. Zivkovic has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alnylam .
Gregory Gruener, MD	Dr. Gruener has nothing to disclose.